Skip to main content

Table 1 Summary of the mechanisms employed by HBV to counteract induction of an efficient interferon response in infected cells

From: Innate immune responses in hepatitis B virus (HBV) infection

Experimental model

Mechanism

HBV protein involved

Functional outcome

Reference

Human hepatocyte cell line

Inhibition of IRF3

HBV polymerase

Inhibition of IFN-β induction

[52]

Hepatoma cell lines, liver tumor samples

MAVS degradation

HBx

Prevention of IFN-β induction

[55]

Hepatoma cell lines

Blocking DDX3 DEAD box RNA helicase

HBV polymerase

Inhibition of IFN-β promoter in response to RIG-I/MDA5 and TLR3

[51]

Hepatoma cell lines, HBx transgenic mouse

HBx binding to IPS-1

HBx

Inhibition of IFN-β induction

[54]

Hepatoma cell lines

Binding and inactivation of mitochondrial membrane protein virus-induced signalling adaptor (VISA)

HBx

Inhibition of virus-triggered IRF3 activation and IFN-β induction

[53]

HBV transgenic mice and hepatoma cell lines

 

HBsAg, HBeAg, or HBV virions

Suppression of TLR 1-9 induced activation of IRF3, NF-κB, ERK1/2 and IFN-β production

[58]

VSV infection of hepatoma cell lines and monocyte-derived dendritic cells from patients with HBV infection

  

Reduced RIG-I expression and IFN-β production

[50]